The English website of the "Alessandra Graziottin Foundation" boosted on line

Back to Scientific Updates

19/10/2009

Hormonal therapy after menopause

Graziottin A.
Hormonal therapy after menopause
in: Porst H. Buvat J. (Eds), ISSM (International Society of Sexual Medicine) Standard Committee Book, Standard practice in Sexual Medicine, Blackwell, Oxford, UK, 2006, p. 362-373

Menopause is characterized by the exhaustion of the ovarian production of oocytes, estrogens and progesterone, with consequent permanent amenorrhea, anovulation and sterility. The ovarian production of testosterone is gradually reduced from the twenties onwards, but is maintained across natural menopause. It is completely lost in surgical menopause (bilateral oophorectomy).
The loss of sexual hormones has a widespread effect on all systems and organs, as virtually all cells of the female body have receptors for sexual hormones. This loss accelerates the negative multi-systemic effects of ageing, with a further detrimental effect.
With the current level of evidence, HT should only be prescribed when it is clearly indicated, primarily for symptom relief. In this context, there is no effective alternative to estrogen or estrogen/progestogen treatment. HT has numerous beneficial effects, if prescribed soon after the menopause, when the “window of opportunity” potentiates its beneficial impact on likely healthy organs and tissue. The need to continue with treatment and the indications for HT should be reviewed regularly when used in the long term. Constant updating is required in the rapidly evolving field of menopausal management.

top

Available documents:
Full text of the chapter

08/02/2010 - Depression and the menopause: why antidepressants are not enough?

25/01/2010 - Testosterone substitution therapy and women's sexual health

30/11/2009 - Anatomy and physiology of women's sexual function

02/11/2009 - Sexual arousal disorders in women

07/09/2009 - Premature ovarian failure: frequency and risk factors among women attending a network of Menopause Clinics in Italy

29/06/2009 - Premature menopause and sexual outcomes

22/06/2009 - Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy

15/06/2009 - Effect of premature menopause on sexuality

19/01/2009 - Premature menopause: the challenge of accelerated sexual aging

12/05/2008 - Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis

Keywords:
Breast Cancer - Gynaecologic Cancer - Cystitis - Depression - Female Dyspareunia - Vulvar Dystrophy - Sexual Pain Disorders - Female Sexual Disorders - Joint's Pain - Endometriosis - Estrogens - Phytoestrogens - Urinary Incontinence - Memory - Natural Menopause - Iatrogenic Menopause - Premature Ovarian Failure (POF) - Menstruation/Period Dysfunctions - Progesterone/Progestins - Doctor-Patient Relationship - Uro-Gynaecologic Rehabilitation - Vaginal Dryness - Sleep/Sleep Disorders - Lifestyles - Hormone Replacement Therapy (HRT) - Testosterone - Vaginitis - Vulvar Vestibulitis/Vulvodynia - Vulvitis - Vulvo-Vaginitis

FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).

WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.

Back to Scientific Updates

C.F./P.IVA: 060 829 20 965

Terms and conditions - Privacy policy - Credits